Boland Lab - Genevieve M. Boland, MD, PhD
The Boland Lab at Massachusetts General Hospital focuses on blood-based techniques for assessing changes in the tumor microenvironment through analysis of circulating exosomes.
Safe Care CommitmentGet the care you need even during COVID-19.Learn more
The Boland Lab at Massachusetts General Hospital focuses on blood-based techniques for assessing changes in the tumor microenvironment through analysis of circulating exosomes.
Research topics in the Cusack Laboratory include molecular targeted therapies for colorectal cancer, melanoma, Merkel cell cancer and carcinomatosis, and improving delivery of surgical cancer care in resource-limited settings.
The Hughes Lab developed a cancer risk assessment software (Hughes riskApps™) that focuses on increasing the quality and efficiency of care while decreasing cost.
The Lubitz Lab focuses on improving the quality of care for patients with thyroid, parathyroid and adrenal disorders.
Research topics in the Maheswaran Lab include tumorigenesis, breast cancer and cancer genetics.
The Oncolytic Virus Laboratory at Massachusetts General Hospital seeks to understand how oncolytic viruses, a new class of tumor immunotherapy or cancer treatment, mediate antitumor activity.
Research topics in the Tanabe Lab include hepatobiliary cancer, Epidermal Growth Factor and hepatocellular carcinoma.
The Xinhui Wang, MD, PhD, Laboratory at Massachusetts General Hospital is focused on two major research initiatives: targeting cancer stem cells and immunotherapy for cancers.
Have an immediate impact on the lives of patients and ensure a healthy future for everyone we take care of at home and abroad.